Stock Taper
SCREENER COMPARE ANY 2 STOCKS
AORT
ARTIVION, INC.
NYSE
$26.77
▲ UP 0.37% (0.10)

KEY STATISTICS

Market Cap$1.30 B
52w High$48.25
52w Low$19.16
Dividend Yield1.15%
FrequencyQuarterly
P/E44.62
Volume466.49K
Shares Out.48.54M

COMPANY

LEADERSHIP

James Patrick Mackin
CHIEF EXECUTIVE
James Patrick Mackin

COMPENSATION 2026

Salary$835,145
Stock Awards$5,006,990
Incentive Plan Pay$991,368
All Other Comp.$49,605
Total$6,883,108

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 12, 1993
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
1,800

PRICE TARGET

Target High$45.00
Target Low$40.00
Target Median$42.50
Target Consensus$42.50

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$120.93M
NOV
5
THU

SPLIT RECORD

DATETYPERATIO
2000-12-28Forward3:2
1996-07-01Forward2:1

PRICE

$26.77 ▲ UP 0.37% (+$0.10)
OVERLAYS
$26.70$26.85$27.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM26.77

About Artivion, Inc.

https://artivion.com ↗

Artivion Inc. manufactures and distributes medical devices and implantable tissues, including grafts, valves, and surgical products, serving healthcare providers worldwide.

INDUSTRY

Medical - Devices

A PRODUCT ARTIVION, INC. IS KNOWN FOR

NEXUS Aortic Arch Stent Graft System
NEXUS Aortic Arch Stent Graft System

An FDA Breakthrough Device-designated endovascular stent graft system offers a minimally invasive solution for repairing aortic arch lesions in high-risk patients.

COMPETITORS

COMPETITOR
BSX COMPARE
EW COMPARE
LMAT COMPARE
MDT COMPARE
MMSI COMPARE

Revenue by Products

IconPRODUCTQ2-2025Q4-2025Q1-2026Q2-2026
Aortic Stent Grafts$39.84M $82.93M ▲$44.4M ▼$46.41M ▲
On X$25.57M $54.59M ▲$25.95M ▼$30.51M ▲
Preservation Services$25.53M $49.8M ▲$24.89M ▼$25.85M ▲
Surgical Sealants$19.29M $39.21M ▲$18.8M ▼$19.29M ▲
Other Products$2.74M $2.85M ▲$2.29M ▼$3.7M ▲

Revenue by Geography

MapREGIONQ2-2025Q4-2025Q1-2026Q2-2026
North America Segment$57.57M $116.38M ▲$58.7M ▼$62.33M ▲
Europe the Middle East and Africa Segments$38.71M $75.61M ▲$43.99M ▼$44.55M ▲
Asia Pacific Segment$11.13M $24.91M ▲$8.69M ▼$12.17M ▲
Latin America Segment$5.56M $12.48M ▲$4.97M ▼$6.71M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
145
LISTED HERE
26
RANKED BY POSITION SIZE
XSMC.TO
0.06% · 2.6M
VTS.AX
0.00% · 1.5M
SPSM
0.06% · 399.1K
XSMO
0.22% · 249.2K
SCHA
0.02% · 203.7K
NANC
1.75% · 190.3K
DOCT.L
1.44% · 178.2K
DFMC
0.06% · 171.5K
PSC
0.10% · 99.9K
HTEC
1.44% · 42.2K
XRS2.DE
0.04% · 41.9K
SIXL
0.29% · 22.1K
RSSL
0.04% · 21.7K
FHLC
0.02% · 20.6K
ZSML.TO
0.06% · 4.1K
SCAP
0.52% · 3.9K
SYZ
0.15% · 3.8K
TILT
0.00% · 3.6K
FLQS
0.15% · 2.6K
ESSC
0.17% · 2.3K
URTY
0.02% · 1.9K
JSTC
0.02% · 1.3K
EBIT
0.25% · 1.1K
BUYO
0.17% · 1.0K
FESC
0.45% · 405
USFMDN.MX
0.00% · 217

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book3
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Gilbert Cisneros
Gilbert Cisneros
Sale (Partial)
2025-10-09
SENATE TRADES
Tina Smith
Tina Smith
Purchase
2023-11-16
HOUSE TRADES
Josh Gottheimer
Josh Gottheimer
Purchase
2023-07-14

INSIDER TRADES

★
OFFICER: PRESIDENT & CEO
Mackin James P
Sale · 70.0K shares
2026-08-19
★
OFFICER: SVP, REGULATORY AND QUALITY
GREEN ANDREW M
Sale · 616 shares
2026-08-14
★
OFFICER: EVP, COO, CFO & TREASURER
Berry Lance A
Sale · 715 shares
2026-08-14
★
OFFICER: SVP, GENERAL COUNSEL
Holloway Jean F
Sale · 977 shares
2026-08-12

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
MARKET OUTPERFORM 2
6 GRADES IN THE LAST 12 MONTHS
Canaccord Genuity BUY Needham BUY Citizens MARKET OUTPERFORM Ladenburg Thalmann BUY JMP Securities MARKET OUTPERFORM Stifel BUY

SECTORS PEERS

PEERPRICE
LQDA$67.69COMPARE
COGT$34.67COMPARE
LFST$12.31COMPARE
ITGR$125.33COMPARE
BKD$11.72COMPARE
ADUS$115.55COMPARE
INSP$61.44COMPARE
ARDT$10.96COMPARE